ライフサイエンスコーパス: occupational therapy

1 re, respiratory medicine, physiotherapy, and occupational therapy.

2 s required, and providing early physical and occupational therapy.

3 ncology, nutrition, speech, and physical and occupational therapy.

4 who provide their patients with psychosocial occupational therapy.

5 83), and in black patients physiotherapy and occupational therapy (0.32, 0.11 to 0.92).

6 ntilated patients receiving physical therapy/occupational therapy (48% vs 26%; p </= 0.001).

7 [9.1] years), 381 received physiotherapy and occupational therapy and 381 received no therapy.

8 sedative interruption and early physical and occupational therapy and to specify details of intensive

9 assessment, nurse assessment, physiotherapy, occupational therapy, and assessment of communication an

10 utpatient services, including physiotherapy, occupational therapy, and multidisciplinary teams.

11 t care, involving nursing, physical therapy, occupational therapy, and respiratory therapy practition

12 It is unclear whether physiotherapy and occupational therapy are clinically effective and cost-e

13 Physical and occupational therapy are possible immediately after intu

14 (0.18% per quarter; P=0.027), physiotherapy/occupational therapy assessment (0.25% per quarter; P<0.

15 oup (n=184) underwent a detailed medical and occupational-therapy assessment with referral to relevan

16 were allocated randomly to up to 5 months of occupational therapy at home or to no intervention (cont

17 rgical options, as well as physiotherapy and occupational therapy, but evidence is inconclusive for m

18 Occupational therapy can improve activities of daily liv

19 pairment measures, performance testing in an occupational therapy clinic, and performance testing in

20 ollaborative care plus 2 years of home-based occupational therapy delays functional decline.

21 ollaborative care plus 2 years of home-based occupational therapy delays functional decline.

22 the intervention group also received in-home occupational therapy delivered in 24 sessions over 2 yea

23 on Program [ASAP]; n = 119); dose-equivalent occupational therapy (DEUCC; n = 120); or monitoring-onl

24 arly exercise and mobilisation (physical and occupational therapy) during periods of daily interrupti

25 dative interruption followed by physical and occupational therapy every hospital day until achieving

26 of tDCS while undergoing usual care physical/occupational therapy for the arm and hand.

27 185 patients were included: 94 in the occupational therapy group and 91 in the control group.

28 At 6 months the improvement in the occupational therapy group was significantly greater tha

29 At follow-up, patients who had occupational therapy had significantly higher median sco

30 nt-centered, goal-directed physiotherapy and occupational therapy in patients in the early stages of

31 of interruption of sedation and physical and occupational therapy in the earliest days of critical il

32 es have demonstrated that early physical and occupational therapy, including during the period of int

33 We aimed to assess the efficacy of an occupational therapy intervention for patients with stro

34 Targeted, comprehensive occupational therapy intervention improves functional an

35 ivity in employed patients with RA receiving occupational therapy intervention versus usual care.

36 Physical therapy/occupational therapy involvement in mobility events was

37 Physical therapy/occupational therapy involvement in mobility was strongl

38 Early physical and occupational therapy is feasible from the onset of mecha

39 tilated patients received early physical and occupational therapy occurring a median of 1.5 days (ran

40 ization protocols include dedicated physical/occupational therapy (odds ratio, 3.34; 95% CI, 2.13-5.2

41 y interruption of sedation with physical and occupational therapy on functional outcomes in patients

42 as created by a team representing optometry, occupational therapy, ophthalmology, neuropsychology, an

43 ge group knew about coverage for physical or occupational therapy or for assistive devices.

44 g (ADL) were randomized to physiotherapy and occupational therapy or no therapy.

45 omly assigned to receive either psychosocial occupational therapy or skills training for 12 hours wee

46 izophrenia after treatment with psychosocial occupational therapy or social skills training, with the

47 h-risk (>or=17) groups, then randomized into occupational therapy or usual care groups.

48 (88%) required physical therapy (PT) and/or occupational therapy (OT).

49 f more structured and intensive physical and occupational therapy programs in patients with all stage

50 portion of patient-days with any physical or occupational therapy-provided mobility event.

51 The prevalence of physical therapy/occupational therapy-provided mobility was 32% (247/770)

52 spiratory failure patients, physical therapy/occupational therapy-provided mobility was infrequent.

53 Symptomatic care and rigorous physical and occupational therapy remain critical components of a com

54 ring 15% (n = 26 of 168) of all physical and occupational therapy sessions (median distance of 15 fee

55 e edge of the bed in 69% of all physical and occupational therapy sessions, transferred from bed to c

56 Occupational therapy significantly reduced disability an

57 rted presence of a dedicated physical and/or occupational therapy team for the ICU.

58 e whether the addition of 2 years of in-home occupational therapy to a collaborative care management

59 e whether the addition of 2 years of in-home occupational therapy to a collaborative care management

60 therapy (DEUCC; n = 120); or monitoring-only occupational therapy (UCC; n = 122).

61 Extensive rehabilitation with physical and occupational therapy was required for several months.

62 The aim of the occupational therapy was to encourage independence in pe

63 Physiotherapy and occupational therapy were not associated with immediate